Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $12,428 - $15,091
-1,028 Closed
0 $0
Q3 2021

Oct 22, 2021

SELL
$13.25 - $15.13 $2,133 - $2,435
-161 Reduced 13.54%
1,028 $14,000
Q2 2021

Jul 27, 2021

BUY
$12.97 - $16.15 $479 - $597
37 Added 3.21%
1,189 $17,000
Q1 2021

Apr 16, 2021

SELL
$13.59 - $18.54 $5,327 - $7,267
-392 Reduced 25.39%
1,152 $16,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $22,079 - $28,934
1,544 New
1,544 $29,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Ade, LLC Portfolio

Follow Ade, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ade, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ade, LLC with notifications on news.